BMRN
$65.43
Revenue | $745.74Mn |
Net Profits | $106.08Mn |
Net Profit Margins | 14.22% |
Biomarin Pharmaceutical Inc.’s revenue jumped 27.27% since last year same period to $745.74Mn in the Q3 2024. On a quarterly growth basis, Biomarin Pharmaceutical Inc. has generated 5.23% jump in its revenue since last 3-months.
Biomarin Pharmaceutical Inc.’s net profit jumped 162.72% since last year same period to $106.08Mn in the Q3 2024. On a quarterly growth basis, Biomarin Pharmaceutical Inc. has generated -1.02% fall in its net profits since last 3-months.
Biomarin Pharmaceutical Inc.’s net profit margin jumped 106.43% since last year same period to 14.22% in the Q3 2024. On a quarterly growth basis, Biomarin Pharmaceutical Inc. has generated -5.94% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.52 |
EPS Estimate Current Year | 0.52 |
Biomarin Pharmaceutical Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.52 - a 48.57% jump from last quarter’s estimates.
Biomarin Pharmaceutical Inc.’s earning per share (EPS) estimates for the current year stand at 0.52.
Earning Per Share (EPS) | 0.55 |
Biomarin Pharmaceutical Inc.’s earning per share (EPS) jumped 161.9% since last year same period to 0.55 in the Q3 2024. This indicates that the Biomarin Pharmaceutical Inc. has generated 161.9% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-04-26 | 0.35 | 0.46 | 31.43% |
2024-10-31 | 0.52 | 0.55 | 5.77% |
2024-08-05 | 0.35 | 0.56 | 60% |